Non-canonical ubiquitin-based signals for proteasomal degradation
暂无分享,去创建一个
[1] Mårten Fryknäs,et al. Inhibition of proteasome deubiquitinating activity as a new cancer therapy , 2011, Nature Medicine.
[2] A. Ciechanover,et al. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation , 2011, Nature Reviews Molecular Cell Biology.
[3] Anindya Dutta,et al. Selective Ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G Ubiquitin-Conjugating Enzymes via the CRL4Cdt2 Ubiquitin Ligase Complex , 2011, Molecular and Cellular Biology.
[4] Anthony W. Purcell,et al. Linear ubiquitination prevents inflammation and regulates immune signalling , 2011, Nature.
[5] B. Maček,et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis , 2011, Nature.
[6] Y. Saeki,et al. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex , 2011, Nature.
[7] S. Gygi,et al. A Perturbed Ubiquitin Landscape Distinguishes Between Ubiquitin in Trafficking and in Proteolysis* , 2011, Molecular & Cellular Proteomics.
[8] Ceri M. Wiggins,et al. BIMEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation , 2011, Journal of Cell Science.
[9] Junmin Peng,et al. Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones , 2011, Neuroscience Letters.
[10] Xianghui Yu,et al. N-Terminal Hemagglutinin Tag Renders Lysine-Deficient APOBEC3G Resistant to HIV-1 Vif-Induced Degradation by Reduced Polyubiquitination , 2011, Journal of Virology.
[11] John Rush,et al. Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.
[12] T. Rando,et al. Taf1 regulates Pax3 protein by monoubiquitination in skeletal muscle progenitors. , 2010, Molecular cell.
[13] A. Goldberg,et al. ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. , 2010, Molecular cell.
[14] A. Philpott,et al. Non-canonical ubiquitylation of the proneural protein Ngn2 occurs in both Xenopus embryos and mammalian cells. , 2010, Biochemical and biophysical research communications.
[15] J. Chin,et al. Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. , 2010, Nature chemical biology.
[16] A. Schwartz,et al. Ubiquitin Proteasome-dependent Degradation of the Transcriptional Coactivator PGC-1α via the N-terminal Pathway* , 2010, The Journal of Biological Chemistry.
[17] Christine Yu,et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. , 2010, Molecular cell.
[18] David Komander,et al. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne , 2010, Nature Structural &Molecular Biology.
[19] J. Larraín,et al. Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan4 , 2010, The Journal of Biological Chemistry.
[20] Min Jae Lee,et al. Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.
[21] T. Hunter,et al. Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors , 2010, Cell cycle.
[22] M. Rapé,et al. Regulated degradation of spindle assembly factors by the anaphase-promoting complex. , 2010, Molecular cell.
[23] Daniel P. Stewart,et al. Ubiquitin-Independent Degradation of Antiapoptotic MCL-1 , 2010, Molecular and Cellular Biology.
[24] H. Ulrich,et al. Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains , 2010, Proceedings of the National Academy of Sciences.
[25] B. André,et al. The ubiquitin code of yeast permease trafficking. , 2010, Trends in cell biology.
[26] G. Du,et al. Dependence of Phospholipase D1 Multi-monoubiquitination on Its Enzymatic Activity and Palmitoylation* , 2010, The Journal of Biological Chemistry.
[27] D. Fushman,et al. Exploring the linkage dependence of polyubiquitin conformations using molecular modeling. , 2010, Journal of molecular biology.
[28] M. Kirschner,et al. UBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting Complex , 2010, Proceedings of the National Academy of Sciences.
[29] W. Weis,et al. Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis* , 2009, The Journal of Biological Chemistry.
[30] Gary H Karpen,et al. Identification of a physiological E2 module for the human anaphase-promoting complex , 2009, Proceedings of the National Academy of Sciences.
[31] Soichi Wakatsuki,et al. Ubiquitin-binding domains — from structures to functions , 2009, Nature Reviews Molecular Cell Biology.
[32] Paul Russell,et al. UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit , 2009, Nature Cell Biology.
[33] A. Ciechanover,et al. Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation , 2009, Proceedings of the National Academy of Sciences.
[34] F. Blasi,et al. Proteomics Analysis of Nucleolar SUMO-1 Target Proteins upon Proteasome Inhibition* , 2009, Molecular & Cellular Proteomics.
[35] S. Gygi,et al. S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains , 2009, The EMBO journal.
[36] Vivian F Su,et al. Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation , 2009, Cellular and Molecular Life Sciences.
[37] Yuanyan Wei,et al. HSP70 protects BCL2L12 and BCL2L12A from N‐terminal ubiquitination‐mediated proteasomal degradation , 2009, FEBS letters.
[38] John Rush,et al. Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation , 2009, Cell.
[39] A. Philpott,et al. Ubiquitylation on Canonical and Non-canonical Sites Targets the Transcription Factor Neurogenin for Ubiquitin-mediated Proteolysis* , 2009, The Journal of Biological Chemistry.
[40] A. Ciechanover,et al. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor. , 2009, Molecular cell.
[41] H. Yokosawa,et al. Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome , 2009, The EMBO journal.
[42] Zhijian J. Chen,et al. Nonproteolytic functions of ubiquitin in cell signaling. , 2009, Molecular cell.
[43] K. Ishii,et al. Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism , 2008, Journal of Virology.
[44] A. Matouschek,et al. Substrate selection by the proteasome during degradation of protein complexes , 2008, Nature chemical biology.
[45] C. Prives,et al. Lysine-Independent Turnover of Cyclin G1 Can Be Stabilized by B′α Subunits of Protein Phosphatase 2A , 2008, Molecular and Cellular Biology.
[46] J. Ou,et al. Ubiquitin-Independent Degradation of Hepatitis C Virus F Protein , 2008, Journal of Virology.
[47] V. Schreiber,et al. The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects' Review Series , 2008, EMBO reports.
[48] Anindya Dutta,et al. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. , 2008, Genes & development.
[49] Youngjo Kim,et al. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. , 2008, Genes & development.
[50] A. Goldberg,et al. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins , 2008, The Journal of cell biology.
[51] A. Sharrocks. Faculty Opinions recommendation of Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. , 2008 .
[52] Ivan Dikic,et al. Atypical ubiquitin chains: new molecular signals , 2008, EMBO reports.
[53] M. Tatham,et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation , 2008, Nature Cell Biology.
[54] M. Lei,et al. Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway , 2008, Nature Cell Biology.
[55] M. Rapé,et al. Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex , 2008, Cell.
[56] Anna M. Keller,et al. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment , 2007, The Journal of cell biology.
[57] S. K. Lim,et al. Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A , 2007, Oncogene.
[58] M. Pagano,et al. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. , 2007, Molecular cell.
[59] T. Rando,et al. Regulation of Pax3 by Proteasomal Degradation of Monoubiquitinated Protein in Skeletal Muscle Progenitors , 2007, Cell.
[60] J. Dewille,et al. Proteasome-mediated CCAAT/enhancer-binding protein δ (C/EBPδ) degradation is ubiquitin-independent , 2007 .
[61] B. O’Malley,et al. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. , 2007, Molecular cell.
[62] James M. Roberts,et al. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.
[63] Steven P Gygi,et al. Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages* , 2007, Journal of Biological Chemistry.
[64] E. Wiertz,et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3 , 2007, The Journal of cell biology.
[65] G. Gopalan,et al. Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway. , 2007, The Biochemical journal.
[66] Aaron Ciechanover,et al. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. , 2006, Molecular cell.
[67] Keiji Tanaka,et al. A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.
[68] S. Gygi,et al. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology , 2006, Nature Cell Biology.
[69] Keith D Wilkinson,et al. The discovery of ubiquitin-dependent proteolysis , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[70] Xuedong Liu,et al. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection. , 2005, Biochemistry.
[71] Beatriz Alvarez-Castelao,et al. Mechanism of direct degradation of IκBα by 20S proteasome , 2005 .
[72] K. Cadwell,et al. Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase , 2005, Science.
[73] Y. Shaul,et al. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. , 2005, Molecular cell.
[74] Y. Shaul,et al. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. , 2005, Genes & development.
[75] James M. Roberts,et al. N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). , 2004, Molecular cell.
[76] Ruchi M. Newman,et al. Antizyme Targets Cyclin D1 for Degradation , 2004, Journal of Biological Chemistry.
[77] A. Ciechanover,et al. The Tumor Suppressor Protein p16INK4a and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System , 2004, Journal of Biological Chemistry.
[78] Mei-Ling Kuo,et al. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. , 2004, Genes & development.
[79] P. Thibault,et al. N-Terminal Ubiquitination of Extracellular Signal-Regulated Kinase 3 and p21 Directs Their Degradation by the Proteasome , 2004, Molecular and Cellular Biology.
[80] Xinbin Chen,et al. MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53* , 2004, Journal of Biological Chemistry.
[81] A. Ciechanover,et al. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. , 2004, Biochemical and biophysical research communications.
[82] M. Dai,et al. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation , 2003, The EMBO journal.
[83] M. Pagano,et al. Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation , 2003, Cell.
[84] Steven P Gygi,et al. A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.
[85] M. Pagano,et al. Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase* , 2003, Journal of Biological Chemistry.
[86] M. Glickman,et al. Proteasome Disassembly and Downregulation Is Correlated with Viability during Stationary Phase , 2003, Current Biology.
[87] K. Davies,et al. Selective degradation of oxidatively modified protein substrates by the proteasome. , 2003, Biochemical and biophysical research communications.
[88] C. Pickart,et al. In Vitro Assembly and Recognition of Lys-63 Polyubiquitin Chains* , 2001, The Journal of Biological Chemistry.
[89] A. Ciechanover,et al. Degradation of the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) by the Ubiquitin-Proteasome Pathway , 2000, The Journal of Biological Chemistry.
[90] B. Clurman,et al. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. , 2000, Molecular cell.
[91] Martin Rechsteiner,et al. Recognition of the polyubiquitin proteolytic signal , 2000, The EMBO journal.
[92] S. Jentsch,et al. A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly , 1999, Cell.
[93] A. Ciechanover,et al. A novel site for ubiquitination: the N‐terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein , 1998, The EMBO journal.
[94] A. Ciechanover,et al. Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .
[95] B. Friguet,et al. The carboxy-terminus of IκBα determines susceptibility to degradation by the catalytic core of the proteasome , 1997, Oncogene.
[96] A. Haas,et al. Novel Multiubiquitin Chain Linkages Catalyzed by the Conjugating Enzymes E2EPF and RAD6 Are Recognized by 26 S Proteasome Subunit 5 (*) , 1996, The Journal of Biological Chemistry.
[97] A. Ciechanover,et al. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[98] S. Matsufuji,et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.
[99] A. Ciechanover,et al. Degradation of ornithine decarboxylase in reticulocyte lysate is ATP-dependent but ubiquitin-independent. , 1989, The Journal of biological chemistry.
[100] D. Ecker,et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. , 1989, Science.
[101] A. Goldberg,et al. Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. , 1987, The Journal of biological chemistry.
[102] A. Goldberg,et al. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. , 1986, The Journal of biological chemistry.
[103] H. Ulrich,et al. The SUMO system: an overview. , 2009, Methods in molecular biology.
[104] J. Dewille,et al. Proteasome-mediated CCAAT/enhancer-binding protein delta (C/EBPdelta) degradation is ubiquitin-independent. , 2007, The Biochemical journal.
[105] Beatriz Alvarez-Castelao,et al. Mechanism of direct degradation of IkappaBalpha by 20S proteasome. , 2005, FEBS letters.
[106] A. Ciechanover,et al. The Tumor Suppressor Protein p 16 INK 4 a and the Human Papillomavirus Oncoprotein-58 E 7 Are Naturally Occurring Lysine-less Proteins , 2004 .
[107] D. Thomas,et al. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome. , 1997, Oncogene.
[108] A. Ciechanover,et al. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. , 1997, The EMBO journal.